News Archive

The U.S. Food and Drug Administration announced today that it has awarded five grants totaling up to $6 million per year over the next five years to Pediatric Device Consortia (PDC) across the country that will provide advice and support services to innovators of children’s medical devices. The program aims to enhance the development, production and distribution of pediatric medical devices and has awarded $37 million to various consortia since 2009.

Enjoy an evening with food, fun and lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community. Complimentary admission for any bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.

When: Thursday, Septmember 27, 2018 4:00-7:00 PM

Where: Farm Brew Live 9901 Discovery Blvd. Manassas, Virginia  20109 United States

Biopharmaceutical, biotech and medical technology companies comprise one of the state’s strongest sectors. They’re crucial to generating new jobs, products and services

Five universities yesterday said they would establish a biotech business incubator at the Shilin-Beitou Technology Park in New Taipei City.

The incubator would the biggest of its kind in northern Taiwan and provide the park, which is still under development, with skilled workers, they said.

None of the four companies with Hopkins-licensed tech that have done IPOs to day are still in Baltimore.

For small businesses currently participating in the federal government’s Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs, understanding intellectual property (IP)—including patents, trade secrets, trademarks, and copyrights—is necessary to protect your ideas, products, and product names in today’s knowledge economy. This series of seven 90-minute webinars, organized by the USPTO and the U.S. Small Business Administration, has been designed to specifically address the most common IP issues facing small businesses funded by the SBIR and STTR programs. They not only cover all aspects of IP protection, but will also help you understand your IP data rights under the SBIR/STTR grant or contract.

Space is limited to 200 people per webinar, so early registration is advised. Please note these webinars are open only to small businesses currently engaged in either Phase 1 or Phase 2 of the SBIR/STTR programs (link is external).

What you get

Participants selected for cohort three will receive: *

• A two-year fellowship – Includes a personal living stipend of up to $90,000/year depending on education and experience, along with health insurance and travel allowance
• Lab access and research funding – In addition to unparalleled access to facilities, equipment, and expertise at Oak Ridge National Laboratory, fellows receive $200,000 of R&D funding to support collaboration opportunities with researchers across the lab.
• Business mentors, entrepreneurial training, and networking – Participants receive access to experienced business mentors, entrepreneurial training programs, and exclusive networking opportunities. Innovators are also exposed to a wide range of leaders from academia, industry, government, and finance that can serve as advisors and partners.

*All support is subject to performance and availability of funds.

Eligibility criteria

For acceptance into the program, applicants:

• Must have PhD or equivalent experience
• Must be focused on energy or manufacturing innovation
• Must leverage ORNL R&D capabilities and have an impact on the Department of Energy (DOE) or Tennessee Valley Authority (TVA) mission
• Must be willing to relocate to the Knoxville-Oak Ridge area
• Must be a US citizen or lawful permanent resident at time of application

To learn more or to apply, please visit: https://innovationcrossroads.ornl.gov/.

World-leading innovation

Discovery crosses industries, border and boundaries in MoCo

After a pair of key milestones this year, a startup working on a new way to treat cancer is opening an office in Baltimore city.

ImmuCision BioTherapeutics is taking office and lab space in the space at the University of Maryland BioPark at 801 Baltimore St.